|
| Summary of the pathogenesis and syndrome differentiation of the traditional Chinese medicine in novel coronavirus pneumonia |
| Hits 1682 Download times 1125 Received:April 09, 2020 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2020.05.07 |
| Key Words
2019 novel coronavirus;pneumonia;symptom and sign;laboratory examination;syndrome differentiation and treatment;integrated traditional Chinese and Western medicine |
| Author Name | Affiliation | E-mail | | XIE Jing | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | GAO Shan | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | LI Lin | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | GAO Shuming | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | XU Yilan | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | xuyilanbjb@163.com | | YU Chunquan | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | ycq-4@163.com |
|
| Abstract
|
| Since December 2019,there have been outbreak pneumonia epidemic with unknown cause in Wuhan,Hubei Province. The virus was then determined to belong to a kind of novel coronavirus by etiological detection. The epidemic caused by this virus is called novel coronavirus pneumonia,which is listed as Class B infectious diseases by the National Health and Health Commission and pre-control measures for Class A infectious diseases are taken. The expert group,composed of academician ZHANG Boli and other experts,went deep into the epidemic area and carried out the prevention and control of traditional Chinese medicine in the epidemic area. This measure effectively controlled the development and outcome of the epidemic,and achieved remarkable results. Therefore,based on the published clinical data,this article compares and analyzes the clinical symptoms,examination,traditional Chinese medicine syndromes and treatment of novel coronavirus pneumonia patients,so as to provide basis for clinical guidance of novel coronavirus pneumonia diagnosis and treatment. |
|
|
|
|
|
|
|
